A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 35
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ADRC
Long Form : Alzheimer's Disease Research Center
No. Year Title Co-occurring Abbreviation
2020 ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies. AD, ADNC, AUC, DLB, LBD, NACC, PD, SNPs
2020 Concordance of Lumipulse cerebrospinal fluid t-tau/Abeta42 ratio with amyloid PET status. Abeta42, AD, AUCs, CSF, PET, ROC
2020 Development of Classification Models for the Prediction of Alzheimer's Disease Utilizing Circulating Sex Hormone Ratios. AD, LR, RP, WHAT-Cog
2020 Informed Consent in Two Alzheimer's Disease Research Centers: Insights From Research Coordinators. AD, eConsent, IC
2020 The U-ARE Protocol: A Pragmatic Approach to Decisional Capacity Assessment for Clinical Research. ---
2019 Comparison of the Short Test of Mental Status and the Montreal Cognitive Assessment Across the Cognitive Spectrum. CN, MCI, MCSA, MoCA, STMS
2019 Evaluation of Medicare Claims Data as a Tool to Identify Dementia. ---
2019 Higher Body Mass Index Is Associated with Lower Cortical Amyloid-beta Burden in Cognitively Normal Individuals in Late-Life. AD, BMI
2019 Retention of Alzheimer Disease Research Participants. ---
10  2018 Application of the condensed protocol for the NIA-AA guidelines for the neuropathological assessment of Alzheimer's disease in an academic clinical practice. AD, CP, NIA-AA, UW
11  2018 Minimizing the Sample Sizes of Clinical Trials on Preclinical and Early Symptomatic Stage of Alzheimer Disease. AD, WU
12  2017 Attitudes toward clinical trials across the Alzheimer's disease spectrum. AD, CI, MCI, OR, UCLA
13  2016 Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease. AD, CDR, CSF
14  2016 Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels. Abeta42, AD, CDR, CSF, GDS, MCBP, MMSE, NPI-Q, p-tau181, PiB, POMS-SF, WU
15  2015 Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results. AD
16  2015 Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory. ADNI, BDNF, Met, Val
17  2015 Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). ADAD, ADNI, DIAN, LOAD, NPC
18  2014 Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation. ACE, AD, ADNI, CSF, IL-6R, MMP3
19  2012 11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder. Abeta42, AD, CSF, HIV
20  2012 A model for the design and implementation of a participant recruitment registry for clinical studies of older adults. ---
21  2012 Genome-wide association study of Alzheimer's disease with psychotic symptoms. AD, AD-P, APOE, GERAD1, GWASs, NIA-LOAD, SNPs
22  2011 An interdisciplinary outreach model of African American recruitment for Alzheimer's disease research. ---
23  2011 Importance of symptomatic cerebral infarcts on cognitive performance in patients with Alzheimer's disease. AD
24  2010 Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: the essential role of the neuropathology core. ADNI, NACC, NPC
25  2009 Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA). AD, BLSA, NIA
26  2009 Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome. ADPR, AED, EEG
27  2006 Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. FTLD, PGRN
28  2006 On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease. AD
29  2004 Progressive posterior cortical dysfunction: a clinicopathologic series. AD, CDR, DAT, PPCD
30  2003 Testing correlation of cognitive decline at adjacent stages of dementia. ---
31  2001 Using "good and bad surprises" to guide improvement efforts: insights from a memory assessment clinic. ---
32  1998 Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. AD, APOE, UCSD
33  1998 Differentiating drivers with dementia of the Alzheimer type from healthy older persons with a Traffic Sign Naming test. DAT
34  1998 Validity of the Quality of Well-Being Scale for patients with Alzheimer's disease. QWB
35  1995 Geographically overlapping Alzheimer's disease registries: comparisons and implications. ADPR